460.192—Ongoing monitoring after trial period.
(a)
At the conclusion of the trial period, CMS, in cooperation with the State administering agency, continues to conduct reviews of a PACE organization, as appropriate, taking into account the quality of care furnished and the organization's compliance with all of the requirements of this part.
(b)
Reviews include an on-site visit at least every 2 years.